Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OncoVax cancer vaccine comprised of patients' attenuated tumor cells and the company's undisclosed adjuvant data

PerImmune said that its vaccine significantly increased disease-free survival compared to

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE